CABT-B11957

antibody from Creative Diagnostics
Targeting: GZMA CTLA3, HFSP
Provider product page for CABT-B11957
Flow cytometry

Antibody data

Product number
CABT-B11957 - Provider product page
Provider
Creative Diagnostics
Product name
Human anti-Human GZMA recombinant monoclonal antibody, clone SFB273
Antibody type
Monoclonal
Description
It recognozes granzyme A, a member of serine protease family expressed exclusively by cytotoxic T lymphocytes and natural killer (NK) cells. Granzyme A is a homodimeric protease and is one of the five granzymes expressed by humans. Also known as granule enzymes, granzymes comprise majority of the mass of cytolytic granules in cytotoxic T lymphocytes (CTLs) and NK cells. NK cells and \u03b3\u03b4 T cells express granzymes constitutively, whereas expression in T lymphocytes is stimulation dependent. Main function attributed to granzymes is to indue apoptotic death of infected and transformed cells. Granzymes other than granzyme B, exert relatively weaker apoptotic activity. Additional reported functions of granzyme A include, to facilitate the migration of T and NK cells and induction of cytokine secretion. Additional information: It displays negligible binding to Fc receptors.
Reactivity
Human
Host
Human
Conjugate
Unconjugated
Isotype
IgG
Antibody clone number
SFB273
Vial size
100 _g in 100 _L
Storage
Store protected from light at 2ÿ8 °C. Do not freeze.
GZMA protein structure - CABT-B11957 shown in red.